JP2005513014A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513014A5
JP2005513014A5 JP2003543603A JP2003543603A JP2005513014A5 JP 2005513014 A5 JP2005513014 A5 JP 2005513014A5 JP 2003543603 A JP2003543603 A JP 2003543603A JP 2003543603 A JP2003543603 A JP 2003543603A JP 2005513014 A5 JP2005513014 A5 JP 2005513014A5
Authority
JP
Japan
Prior art keywords
dosage unit
analog
range
present
suitable excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003543603A
Other languages
English (en)
Japanese (ja)
Other versions
JP4852229B2 (ja
JP2005513014A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2002/011862 external-priority patent/WO2003041716A1/en
Publication of JP2005513014A publication Critical patent/JP2005513014A/ja
Publication of JP2005513014A5 publication Critical patent/JP2005513014A5/ja
Application granted granted Critical
Publication of JP4852229B2 publication Critical patent/JP4852229B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003543603A 2001-11-14 2002-11-14 便秘の処置用のプロスタグランジンアナログを含む用量単位 Expired - Lifetime JP4852229B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33131601P 2001-11-14 2001-11-14
US60/331,316 2001-11-14
PCT/JP2002/011862 WO2003041716A1 (en) 2001-11-14 2002-11-14 Dosage unit comprising a prostaglandin analog for treating constipation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011117231A Division JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Publications (3)

Publication Number Publication Date
JP2005513014A JP2005513014A (ja) 2005-05-12
JP2005513014A5 true JP2005513014A5 (https=) 2006-01-12
JP4852229B2 JP4852229B2 (ja) 2012-01-11

Family

ID=23293447

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003543603A Expired - Lifetime JP4852229B2 (ja) 2001-11-14 2002-11-14 便秘の処置用のプロスタグランジンアナログを含む用量単位
JP2011117231A Pending JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011117231A Pending JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Country Status (14)

Country Link
US (3) US8097653B2 (https=)
EP (2) EP2298314B1 (https=)
JP (2) JP4852229B2 (https=)
AR (3) AR037524A1 (https=)
AT (1) ATE522218T1 (https=)
BR (1) BR0214075A (https=)
CA (1) CA2464420C (https=)
CY (1) CY1115856T1 (https=)
DK (2) DK1443938T3 (https=)
ES (2) ES2524369T3 (https=)
LU (1) LU92826I2 (https=)
PT (2) PT2298314E (https=)
TW (1) TWI331920B (https=)
WO (1) WO2003041716A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
DK1562604T3 (da) * 2002-10-23 2012-04-02 Sucampo Ag Prostaglandinforbindelser til behandling af fedme
BRPI0317740B8 (pt) * 2002-12-27 2021-05-25 Sucampo Ag uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1
ATE489096T1 (de) * 2003-07-03 2010-12-15 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
ES2714198T3 (es) * 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
WO2006109881A1 (en) * 2005-04-12 2006-10-19 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
CA2637274C (en) * 2006-01-24 2013-06-04 R-Tech Ueno, Ltd. Soft-gelatin capsule formulation
EP1984027B1 (en) 2006-01-24 2015-12-30 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090012165A1 (en) 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
CA2774021A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of opioid receptor antagonist for gastrointestinal tract disorders
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5350141A (en) * 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
GB1581886A (en) 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
EP0310305B1 (en) * 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartics
JPH0681728B2 (ja) 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030344C (en) 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2046069C (en) 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
JP2938579B2 (ja) 1990-12-15 1999-08-23 株式会社上野製薬応用研究所 消化管壁保護剤
EP0503887B1 (en) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Promotion of wound-healing with 15-keto-prostaglandin compounds
EP0554794B1 (en) * 1992-02-04 1998-07-29 Eisai Co., Ltd. Aminobenzoic acid derivatives
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP3187438B2 (ja) * 1996-06-10 2001-07-11 株式会社アールテック・ウエノ エンドセリン拮抗剤
DE19717005A1 (de) * 1997-04-23 1998-10-29 Kennametal Inc Spannfutter für Rundlaufwerkzeuge
ES2310013T3 (es) * 1997-11-28 2008-12-16 Sucampo Ag Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina.
US6492417B1 (en) 1997-12-22 2002-12-10 Alcon Manufacturing, Ltd. 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists
RU2695274C3 (ru) * 1999-10-15 2020-11-09 Сукампо Аг Новые композиции и способы их стабилизации
NZ521784A (en) 2000-04-06 2005-04-29 Sucampo Ag Bile secretion promoting composition
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
WO2002094274A1 (en) 2001-05-18 2002-11-28 Sucampo Ag Cathartic composition
EP1420794B1 (en) * 2001-08-31 2017-12-27 Sucampo AG Prostaglandin analogs as chloride channel openers
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
BRPI0317740B8 (pt) * 2002-12-27 2021-05-25 Sucampo Ag uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1

Similar Documents

Publication Publication Date Title
JP2005513014A5 (https=)
JP2003531118A5 (https=)
JP2005533860A5 (https=)
JP2006182786A5 (https=)
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
IL160028A (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
JP2004508410A5 (https=)
RU2002123350A (ru) Дипептиднитрильные ингибиторы катепсина К
JP2005508337A5 (https=)
JP2003503449A5 (https=)
JP2007176958A (ja) セチリジン及びプソイドエフェドリンを含む錠剤
CA2464420A1 (en) Dosage unit comprising a prostaglandin analog for treating constipation
CN1107706A (zh) 抑制皮脂溢和痤疮的方法
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
JP2004532828A5 (https=)
JP2001520994A5 (https=)
JP2002509164A5 (https=)
CN1172669C (zh) 沙利度坦在制造治疗或预防主要抑郁性病症的药物中的应用
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
JPH1036365A5 (https=)
JP2005524666A5 (https=)
JPH02233613A (ja) ピペリジノアルカノール誘導体類用の液体製剤組成物
JP2004514709A5 (https=)
JP2005515155A5 (https=)